pharmacists as part of an "early warning system" to help identify problems with newly approved drugs

You'll hear about a proposal to rely more on pharmacists as part of an "early warning system" to help identify problems with newly approved drugs.

In the last three years, the FDA has had to take seven drugs off the market...Rezulin, Propulsid, Redux, Pondimin, Posicor, Seldane, and Duract.

The FDA currently relies on voluntary reports to monitor new drugs for adverse reactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote